Abstract:Glioblastoma multiforme (GBM) is the most aggressive glioma. The treatment response is always low, and the condition is typically rapidly fatal. The undifferentiated and self-renewal characteristics of cancer stem cells (CSCs) have been reported, and their potential contribution may cause tumor initiation, recurrence, metastasis, and therapeutic resistance. In particular, glioblastoma stem-like cells exhibit highly invasive properties and drug resistance, serving as a model for the development of novel therapeutic strategies. Induction therapy provides an alternative therapeutic strategy to eliminate the stem cell properties of CSCs and enhance therapeutic sensitivity. The differentiated cells may lose their self-renewal ability, downregulate stem cell-related genes and drug resistance genes, and enhance anticancer drug sensitivity. Therefore, the purpose of this study is to establish a niche for glioblastoma stem-like cell selection as a platform and facilitate the assessment of differentiation therapy on GBM cancer stem-like colonies by retinoic acid (RA) with temozolomide (TMZ)-loaded gold nanoparticles (GNPs) associated with low-intensity ultrasound (LIUS). Herein, a hyaluronic acid-based material system was used to isolate GBM cancer stem-like colonies. Colony formation, size determination, stem cell-related marker expression, and GBM cancer stem-like cell marker expression with the culture period were identified. The effect of TMZ on GBM stem-like colonies on HA-based material systems was also determined, and the results revealed that drug resistance was highly enhanced in GBM colonies compared with that in the control cell population. In addition, GBM colonies also exhibited a significant increase in breast cancer resistance protein expression, which is consistent with the drug resistance effect. Furthermore, several factors, including LIUS, RA, and GNPs, were used to determine the possibility of induction therapy. RA with TMZ-loaded GNP-associated LIUS stimulation exhibited a significant and synergistic effect on the differentiation effect and drug sensitivity enhancement. The GBM cancer stem-like colony system presents an opportunity for the development of new therapeutic strategies, and this study provides an alternative differentiation therapy for malignant tumors.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c09634?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c09634</a>.S1: Comparison of spheroid formation and relative survival rate of U87-MG cells seeded on the PEM nanofilms and low-attachment culture plate before and after incubation with increasing concentrations of TMZ, S2: SEM-EDS micrographs of bare GNPs and GNPs loaded with different ratios of TMZ, S3: DLS micrographs and TEM images of size and distribution of bare GNPs and GNPs loaded with different ratios of TMZ, S4 and S5: Size, PDI, and zeta potential measurements of bare GNPs and GNPs with different TMZ loading ratios, respectively, and S6: Long-term stability test of GNPs (PDF)This article has not yet been cited by other publications.

Neuronal Differentiation of Human Glioma Cells Induced by Parthenolide Under In Vitro Conditions

Parthenolide Induces Proliferation Inhibition and Apoptosis of Pancreatic Cancer Cells in Vitro

Effect of Parthenolide on Proliferation and Apoptosis of Human Pancreatic BxPC-3 Cells

Induction of neural differentiation in rat C6 glioma cells with taxol

Growth Inhibition and Induction of Differentiation by Panaxydol in Rat C6 Glioma Cells

Human neural stem cells repress glioma cell progression in a paracrine manner by downregulating the Wnt/β-catenin signalling pathway

Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells

The Inhibiting Effect of Neural Stem Cells on Proliferation and Invasion of Glioma Cells.

Neural Stem Cell-Derived Factors Inhibit the Growth and Invasion of U87 Stem-Like Cells in Vitro

Par-6/aPKC Polarity Protein Rearrangement Promoted Cell Rapid Proliferation and Differentiation of Glioma Side Population Cells

Reprogramming Glioblastoma Cells into Non-Cancerous Neuronal Cells as a Novel Anti-Cancer Strategy

Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells

Chlorogenic Acid Induced Neuroblastoma Cells Differentiation via the ACAT1-TPK1-PDH Pathway

Csig-32. Modulation Of Hallmarks Of Glioblastoma Multiforme By Bioactive Phytochemicals: A Preclinical Mechanistic Evaluation

Phosphatidylinositol 3-Kinase Activity is Required for the Induction of Differentiation in C6 Glioma Cells by Panaxydol.

Study on Relationship Between Differentiation and Autophagy of Glioma Stem/Progenitor Cells

Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies

Autophagy impairment inhibits differentiation of glioma stem/progenitor cells.

PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor

Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell

Effects of Ganglioside GM1 and Neural Growth Factor on Neural Stem Cell Proliferation and Differentiation.